Contrast-induced nephropathy in patients undergoing percutaneous coronary intervention

Cardiology Research and Practice

Volumn 1, Issue 1, 2010, Pages

  Jafferani, Asif ^b   Shoukat, Sana ^a   Gowani, Saqib A ^a   Dhakam, Sajid H ^a  

^a AGA KHAN UNIVERSITY HOSPITAL   (Pakistan)

^b AGA KHAN UNIVERSITY   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ASCORBIC ACID; ATORVASTATIN; ATRIAL NATRIURETIC FACTOR; BICARBONATE; CALCIUM CHANNEL BLOCKING AGENT; CREATININE; DIATRIZOATE; DOPAMINE; FENOLDOPAM; FUROSEMIDE; GADOLINIUM; GLUCOSE; IODINATED CONTRAST MEDIUM; IODIXANOL; IOHEXOL; IOMEPROL; IOPAMIDOL; IOXAGLIC ACID; MANNITOL; PLACEBO; PROSTAGLANDIN E; SIMVASTATIN; SODIUM CHLORIDE; THEOPHYLLINE;

AGE; CONTINUOUS INFUSION; CONTRAST INDUCED NEPHROPATHY; CREATININE BLOOD LEVEL; CRYSTALLOID; DIABETES MELLITUS; DISEASE COURSE; DIURESIS; DRUG DOSE COMPARISON; DRUG MEGADOSE; DRUG SAFETY; FLUID THERAPY; GLOMERULUS FILTRATION RATE; HEMODIALYSIS; HEMOFILTRATION; HUMAN; INCIDENCE; KIDNEY DISEASE; KIDNEY ISCHEMIA; KIDNEY TUBULE DAMAGE; KIDNEY TUBULE EPITHELIUM; LOW DRUG DOSE; MEDICAL RESEARCH; META ANALYSIS (TOPIC); MORBIDITY; MORTALITY; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RENAL PROTECTION; REVIEW; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; SIDE EFFECT;

EID: 79959453976     PISSN: None     EISSN: 20900597     Source Type: Journal    
DOI: 10.4061/2010/649164     Document Type: Review

References (118)

1. Ix J. H., Shlipak M. G., Liu H. H., Schiller N. B., Whooley M. A., Association between renal insufficiency and inducible ischemia in patients with coronary artery disease: the heart and soul study Journal of the American Society of Nephrology 2003 14 12 3233 3238 (Pubitemid 37509298)
2. Anavekar N. S., McMurray J. J. V., Velazquez E. J., Solomon S. D., Kober L., Rouleau J.-L., White H. D., Nordlander R., Maggioni A., Dickstein K., Zelenkofske S., Leimberger J. D., Califf R. M., Pfeffer M. A., Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction New England Journal of Medicine 2004 351 13 1285 1295 (Pubitemid 39258422)
3. Shlipak M. G., Smith G. L., Rathore S. S., Massie B. M., Krumholz H. M., Renal function, digoxin therapy, and heart failure outcomes: evidence from the digoxin intervention group trial Journal of the American Society of Nephrology 2004 15 8 2195 2203 (Pubitemid 39031358)
4. Dimkovi N., Cardiovascular diseases in patients with chronic renal diseases Srpski Arhiv za Celokupno Lekarstvo 2008 136 135 141
5. Ohtake T., Kobayashi S., Moriya H., Negishi K., Okamoto K., Maesato K., Saito S., High prevalence of occult coronary artery stenosis in patients with chronic kidney disease at the initiation of renal replacement therapy: an angiographic examination Journal of the American Society of Nephrology 2005 16 4 1141 1148 (Pubitemid 41710326)
6. Levin A., Clinical epidemiology of cardiovascular disease in chronic kidney disease prior to dialysis Seminars in Dialysis 2003 16 2 101 105 (Pubitemid 37361072)
7. Collins A. J., Cardiovascular mortality in end-stage renal disease American Journal of the Medical Sciences 2003 325 4 163 167 (Pubitemid 36437989)
8. Go A. S., Chertow G. M., Fan D., McCulloch C. E., Hsu C.-Y., Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization New England Journal of Medicine 2004 351 13 1296 1370
9. Mehran R., Nikolsky E., Contrast-induced nephropathy: definition, epidemiology, and patients at risk Kidney International 2006 100, supplement S11 S15
10. Brown J. R., Malenka D. J., DeVries J. T., Robb J. F., Jayne J. E., Friedman B. J., Hettleman B. D., Niles N. W., Kaplan A. V., Schoolwerth A. C., Thompson C. A., Transient and persistent renal dysfunction are predictors of survival after percutaneous coronary intervention: insights from the Dartmouth Dynamic Registry Catheterization and Cardiovascular Interventions 2008 72 3 347 354
11. Sadeghi H. M., Stone G. W., Grines C. L., Mehran R., Dixon S. R., Lansky A. J., Fahy M., Cox D. A., Garcia E., Tcheng J. E., Griffin J. J., Stuckey T. D., Turco M., Carroll J. D., Impact of renal insufficiency in patients undergoing primary angioplasty for acute myocardial infarction Circulation 2003 108 22 2769 2775 (Pubitemid 37498979)
12. Thomsen H. S., Morcos S. K., Contrast media and the kidney: European Society of Urogenital Radiology (ESUR) guidelines British Journal of Radiology 2003 76 908 513 518 (Pubitemid 37028403)
13. Thomsen H. S., Morcos S. K., Contrast-medium-induced nephropathy: is there a new consensus? A review of published guidelines European Radiology 2006 16 8 1835 1840 (Pubitemid 44027388)
14. Brindis R. G., Fitzgerald S., Anderson H. V., Shaw R. E., Weintraub W. S., Williams J. F., The American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR ): building a national clinical data repository Journal of the American College of Cardiology 2001 37 8 2240 2244 (Pubitemid 32548015)
15. Harjai K. J., Raizada A., Shenoy C., Sattur S., Orshaw P., Yaeger K., Boura J., Aboufares A., Sporn D., Stapleton D., A Comparison of contemporary definitions of contrast nephropathy in patients undergoing percutaneous coronary intervention and a proposal for a novel nephropathy grading system American Journal of Cardiology 2008 101 6 812 819
16. Parfrey P., The clinical epidemiology of contrast-induced nephropathy CardioVascular and Interventional Radiology 2005 28 supplement 2 S3 S11
17. Rihal C. S., Textor S. C., Grill D. E., Berger P. B., Ting H. H., Best P. J., Singh M., Bell M. R., Barsness G. W., Mathew V., Garratt K. N., Holmes D. R. Jr., Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention Circulation 2002 105 19 2259 2264 (Pubitemid 34535335)
18. Haller C., Hizoh I., The cytotoxicity of iodinated radiocontrast agents on renal cells in vitro Investigative Radiology 2004 39 3 149 154 (Pubitemid 38263921)
19. McCullough P. A., Radiocontrast-induced acute kidney injury Nephron Physiology 2008 109 4 p61 p72
20. Katholi R. E., Woods W. T. Jr., Taylor G. J., Deitrick C. L., Womack K. A., Katholi C. R., McCann W. P., Oxygen free radicals and contrast nephropathy American Journal of Kidney Diseases 1998 32 1 64 71 (Pubitemid 28311873)
21. Heyman S. N., Reichman J., Brezis M., Pathophysiology of radiocontrast nephropathy: a role for medullary hypoxia Investigative Radiology 1999 34 11 685 691 (Pubitemid 29506070)
22. Dickenmann M., Oettl T., Mihatsch M. J., Osmotic nephrosis: acute kidney injury with accumulation of proximal tubular lysosomes due to administration of exogenous solutes American Journal of Kidney Diseases 2008 51 3 491 503 (Pubitemid 351273478)
23. Moreau J. F., Droz D., Noel L. H., Tubular nephrotoxicity of water-soluble iodinated contrast media Investigative Radiology 1980 15 6 S54 S60
24. Chen S. L., Zhang J., Yei F., Zhu Z., Liu Z., Lin S., Chu J., Yan J., Zhang R., Kwan T. W., Clinical outcomes of contrast-induced nephropathy in patients undergoing percutaneous coronary intervention: a prospective, multicenter, randomized study to analyze the effect of hydration and acetylcysteine International Journal of Cardiology 2008 126 3 407 413 (Pubitemid 351636362)
25. Gussenhoven M. J., Ravensbergen J., van Bockel J. H., Renal dysfunction after angiography; a risk factor analysis in patients with peripheral vascular disease Journal of Cardiovascular Surgery 1991 32 81
26. Dangas G., Iakovou I., Nikolsky E., Aymong E. D., Mintz G. S., Kipshidze N. N., Lansky A. J., Moussa I., Stone G. W., Moses J. W., Leon M. B., Mehran R., Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables American Journal of Cardiology 2005 95 1 13 19 (Pubitemid 40051105)
27. Davidson C. J., Hlatky M., Morris K. G., Pieper K., Skelton T. N., Schwab S. J., Bashore T. M., Cardiovascular and renal toxicity of a nonionic radiographic contrast agent after cardiac catheterization. A prospective trial Annals of Internal Medicine 1989 110 2 119 124 (Pubitemid 19033197)
28. McCullough P. A., Adam A., Becker C. R., Davidson C., Lameire N., Stacul F., Tumlin J., Risk prediction of contrast-induced nephropathy American Journal of Cardiology 2006 98 6 27 36 (Pubitemid 44292092)
29. McCullough P. A., Wolyn R., Rocher L. L., Levin R. N., O'Neill W. W., Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality American Journal of Medicine 1997 103 5 368 375 (Pubitemid 27506242)
30. Nikolsky E., Aymong E. D., Dangas G., Mehran R., Radiocontrast nephropathy: identifying the high-risk patient and the implications of exacerbating renal function Reviews in Cardiovascular Medicine 2003 4 supplement 1 S7 S14
31. Bagshaw S. M., Culleton B. F., Contrast-induced nephropathy: epidemiology and prevention Minerva Cardioangiologica 2006 54 1 109 129 (Pubitemid 43343117)
32. Toprak O., Cirit M., Yesil M., Bayata S., Tanrisev M., Varol U., Ersoy R., Esi E., Impact of diabetic and pre-diabetic state on development of contrast-induced nephropathy in patients with chronic kidney disease Nephrology Dialysis Transplantation 2007 22 3 819 826 (Pubitemid 46351691)
33. Berns A. S., Nephrotoxicity of contrast media Kidney International 1989 36 4 730 740 (Pubitemid 19239569)
34. Marenzi G., Lauri G., Assanelli E., Campodonico J., De Metrio M., Marana I., Grazi M., Veglia F., Bartorelli A. L., Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction Journal of the American College of Cardiology 2004 44 9 1780 1785 (Pubitemid 39424075)
35. Mehran R., Aymong E. D., Nikolsky E., Lasic Z., Iakovou I., Fahy M., Mintz G. S., Lansky A. J., Moses J. W., Stone G. W., Leon M. B., Dangas G., A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation Journal of the American College of Cardiology 2004 44 7 1393 1399 (Pubitemid 39303939)
36. Kahn J. K., Rutherford B. D., McConahay D. R., Johnson W. L., Giorgi L. V., Shimshak T. M., Hartzler G. O., High-dose contrast agent administration during complex coronary angioplasty American Heart Journal 1990 120 3 533 536 (Pubitemid 20312580)
37. Rosovsky M. A., Rusinek H., Berenstein A., Basak S., Setton A., Nelson P. K., High-dose administration of nonionic contrast media: a retrospective review Radiology 1996 200 1 119 122 (Pubitemid 26197348)
38. Kane G. C., Doyle B. J., Lerman A., Barsness G. W., Best P. J., Rihal C. S., Ultra-low contrast volumes reduce rates of contrast-induced nephropathy in patients with chronic kidney disease undergoing coronary angiography Journal of the American College of Cardiology 2008 51 1 89 90
39. Mekan S. F., Rabbani M. A., Azhar-Uddin M., Ali S. S., Radiocontrast nephropathy: is it dose related or not? Journal of the Pakistan Medical Association 2004 54 7 372 374 (Pubitemid 39208493)
40. Laskey W. K., Jenkins C., Selzer F., Marroquin O. C., Wilensky R. L., Glaser R., Cohen H. A., Holmes D. R. Jr., Volume-to-creatinine clearance ratio: a pharmacokinetically based risk factor for prediction of early creatinine increase after percutaneous coronary intervention Journal of the American College of Cardiology 2007 50 7 584 590 (Pubitemid 47199002)
41. Barrett B. J., Carlisle E. J., Metaanalysis of the relative nephrotoxicity of high- and low-osmolality iodinated contrast media Radiology 1993 188 1 171 178 (Pubitemid 23183119)
42. Rudnick M. R., Goldfarb S., Wexler L., Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. The Iohexol Cooperative Study Kidney International 1995 47 254 261
43. Aspelin P., Aubry P., Fransson S.-G., Strasser R., Willenbrock R., Berg K. J., Nephrotoxic effects in high-risk patients undergoing angiography New England Journal of Medicine 2003 348 6 491 499 (Pubitemid 36159884)
44. McCullough P. A., Bertrand M. E., Brinker J. A., Stacul F., A meta-analysis of the renal safety of isosmolar Iodixanol compared with low-osmolar contrast media Journal of the American College of Cardiology 2006 48 4 692 699 (Pubitemid 44175706)
45. Jo S.-H., Youn T.-J., Koo B.-K., Park J.-S., Kang H.-J., Cho Y.-S., Chung W.-Y., Joo G.-W., Chae I.-H., Choi D.-J., Oh B.-H., Lee M.-M., Park Y.-B., Kim H.-S., Renal toxicity evaluation and comparison between visipaque (iodixanol) and hexabrix (ioxaglate) in patients with renal insufficiency undergoing coronary angiography. The recover study: a randomized controlled trial Journal of the American College of Cardiology 2006 48 5 924 930 (Pubitemid 44308573)
46. Mehran R., ICONa prospective, randomized, placebo-controlled trial of ioxaglate vs iodixanol in patients at increased risk for contrast nephropathy. TCT, 2006
47. Solomon R. J., Natarajan M. K., Doucet S., Sharma S. K., Staniloae C. S., Katholi R. E., Gelormini J. L., Labinaz M., Moreyra A. E., Cardiac angiography in renally impaired patients (CARE) study: a randomized double-blind trial of contrast-induced nephropathy in patients with chronic kidney disease Circulation 2007 115 25 3189 3196 (Pubitemid 47012233)
48. Nicholson T., Downes M., Contrast nephrotoxicity and iso-osmolar contrast agents: implications of NEPHRIC Clinical Radiology 2003 58 9 659 660 (Pubitemid 37045691)
49. Thomsen H. S., Morcos S. K., Erley C. M., Grazioli L., Bonomo L., Ni Z., Romano L., Bader T., Benea G., Catalano C., Chen K.-M., Feng X.-Y., Hellstrm M., Morana G., Pozzi-Mucelli R., Reimer P., Tasu J. P., Wright A., Yang L., The ACTIVE trial: comparison of the effects on renal function of iomeprol-400 and iodixanol-320 in patients with chronic kidney disease undergoing abdominal computed tomography Investigative Radiology 2008 43 3 170 178 (Pubitemid 351643143)
50. Persson P. B., Hansell P., Liss P., Pathophysiology of contrast medium-induced nephropathy Kidney International 2005 68 1 14 22 (Pubitemid 43181360)
51. Bartholomew B. A., Harjai K. J., Dukkipati S., Boura J. A., Yerkey M. W., Glazier S., Grines C. L., O'Neill W. W., Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification American Journal of Cardiology 2004 93 12 1515 1519 (Pubitemid 38749208)
52. Hou S. H., Bushinsky D. A., Wish J. B., Hospital-acquired renal insufficiency: a prospective study American Journal of Medicine 1983 74 2 243 248 (Pubitemid 13192180)
53. Levy E. M., Viscoli C. M., Horwitz R. I., The effect of acute renal failure on mortality: a cohort analysis Journal of the American Medical Association 1996 275 19 1489 1494 (Pubitemid 26140761)
54. Best P. J. M., Lennon R., Ting H. H., Bell M. R., Rihal C. S., Holmes D. R. Jr., Berger P. B., The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions Journal of the American College of Cardiology 2002 39 7 1113 1119 (Pubitemid 34267412)
55. Erley C. M., Does hydration prevent radiocontrast-induced acute renal failure? Nephrology Dialysis Transplantation 1999 14 5 1064 1066 (Pubitemid 29209281)
56. Solomon R., Werner C., Mann D., D'Elia J., Silva P., Effects of saline, mannitol, and furosemide on acute decreases in renal function induced by radiocontrast agents New England Journal of Medicine 1994 331 21 1416 1420 (Pubitemid 24348355)
57. Stevens M. A., McCullough P. A., Tobin K. J., A prospective randomized trial of prevention measures in patients at high risk for contrast nephropathy: results of the P.R.I.N.C.E. Study. Prevention of radiocontrast induced nephropathy clinical evaluation Journal of the American College of Cardiology 1999 33 403
58. Taylor A. J., Hotchkiss D., Morse R. W., McCabe J., PREPARED: preparation for angiography in renal dysfunction: a randomized trial of inpatient vs outpatient hydration protocols for cardiac catheterization in mild-to-moderate renal dysfunction Chest 1998 114 6 1570 1574 (Pubitemid 128487477)
59. Trivedi H. S., Moore H., Nasr S., Aggarwal K., Agrawal A., Goel P., Hewett J., A randomized prospective trial to assess the role of saline hydration on the development of contrast nephrotoxicity Nephron Clinical Practice 2003 93 1 C29 C34
60. Mueller C., Buerkle G., Buettner H. J., Petersen J., Perruchoud A. P., Eriksson U., Marsch S., Roskamm H., Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty Archives of Internal Medicine 2002 162 3 329 336 (Pubitemid 34127411)
61. Stacul F., Adam A., Becker C. R., Davidson C., Lameire N., McCullough P. A., Tumlin J., Strategies to reduce the risk of contrast-induced nephropathy American Journal of Cardiology 2006 98 6 59 77 (Pubitemid 44292094)
62. Briguori C., Airoldi F., D'Andrea D., Bonizzoni E., Morici N., Focaccio A., Michev I., Montorfano M., Carlino M., Cosgrave J., Ricciardelli B., Colombo A., Renal insufficiency following contrast media administration trial (REMEDIAL): a randomized comparison of 3 preventive strategies Circulation 2007 115 10 1211 1217 (Pubitemid 46594764)
63. Recio-Mayoral A., Chaparro M., Prado B., Czar R., Mndez I., Banerjee D., Kaski J. C., Cubero J., Cruz J. M., The reno-protective effect of hydration with sodium bicarbonate plus N-acetylcysteine in patients undergoing emergency percutaneous coronary intervention: the RENO Study Journal of the American College of Cardiology 2007 49 12 1283 1288 (Pubitemid 46467227)
64. Merten G. J., Burgess W. P., Gray L. V., Holleman J. H., Roush T. S., Kowalchuk G. J., Bersin R. M., Van Moore A., Simonton C. A. III, Rittase R. A., Norton H. J., Kennedy T. P., Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial Journal of the American Medical Association 2004 291 19 2328 2334 (Pubitemid 38656299)
65. Bouzas-Mosquera A., Recio-Mayoral A., Sodium bicarbonate, N-acetylcysteine, and saline for the prevention of contrast-induced nephropathy American Heart Journal 2008 155 4, article no. e31
66. Castini D., Lucreziotti S., Bosotti L., Prevention of contrast-induced nephropathy: a single center randomized study Clinical Cardiology 2010 33 3 E63 E68
67. Ozcan E. E., Guneri S., Akdeniz B., Akyildiz I. Z., Senaslan O., Baris N., Aslan O., Badak O., Sodium bicarbonate, N-acetylcysteine, and saline for prevention of radiocontrast-induced nephropathy. A comparison of 3 regimens for protecting contrast-induced nephropathy in patients undergoing coronary procedures. A single-center prospective controlled trial American Heart Journal 2007 154 3 539 544 (Pubitemid 47268251)
68. Vasheghani-Farahani A., Sadigh G., Kassaian S. E., Sodium bicarbonate in preventing contrast nephropathy in patients at risk for volume overload: a randomized controlled trial Journal of Nephrology 2010 23 216
69. Vasheghani-Farahani A., Sadigh G., Kassaian S. E., Khatami S. M. R., Fotouhi A., Razavi S. A. H., Mansournia M. A., Yamini-Sharif A., Amirzadegan A., Salarifar M., Sadeghian S., Davoodi G., Borumand M. A., Esfehani F. A., Darabian S., sodium bicarbonate plus isotonic saline versus saline for prevention of contrast-induced nephropathy in patients undergoing coronary angiography: a randomized controlled trial American Journal of Kidney Diseases 2009 54 4 610 618
70. Kunadian V., Zaman A., Spyridopoulos I., Qiu W., Sodium bicarbonate for the prevention of contrast induced nephropathy: a meta-analysis of published clinical trials. European Journal of Radiology. In press
71. Navaneethan S. D., Singh S., Appasamy S., Wing R. E., Sehgal A. R., Sodium bicarbonate therapy for prevention of contrast-induced nephropathy: a systematic review and meta-analysis American Journal of Kidney Diseases 2009 53 4 617 627
72. Zoungas S., Ninomiya T., Huxley R., Cass A., Jardine M., Gallagher M., Patel A., Vasheghani-Farahani A., Sadigh G., Perkovic V., Systematic review: sodium bicarbonate treatment regimens for the prevention of contrast-induced nephropathy Annals of Internal Medicine 2009 151 9 631 638
73. Clavijo L. C., Pinto T. L., Kuchulakanti P. K., Torguson R., Chu W. W., Satler L. F., Kent K. M., Suddath W. O., Waksman R., Pichard A. D., Effect of a rapid intra-arterial infusion of dextrose 5 prior to coronary angiography on frequency of contrast-induced nephropathy in high-risk patients American Journal of Cardiology 2006 97 7 981 983
74. DiMari J., Megyesi J., Udvarhelyi N., Price P., Davis R., Safirstein R., N-acetyl cysteine ameliorates ischemic renal failure American Journal of Physiology 1997 272 3 F292 F298
75. Tepel M., Van Der Giet M., Schwarzfeld C., Laufer U., Liermann D., Zidek W., Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine New England Journal of Medicine 2000 343 3 180 184 (Pubitemid 30489215)
76. Diaz-Sandoval L. J., Kosowsky B. D., Losordo D. W., Acetylcysteine to prevent angiography-related renal tissue injury (the APART trial) American Journal of Cardiology 2002 89 3 356 358 (Pubitemid 34113804)
77. Azmus A. D., Gottschall C., Manica A., Manica J., Duro K., Frey M., Bulco L., Lima C., Effectiveness of acetylcysteine in prevention of contrast nephropathy Journal of Invasive Cardiology 2005 17 2 80 84 (Pubitemid 41741751)
78. Marenzi G., Assanelli E., Marana I., Lauri G., Campodonico J., Grazi M., De Metrio M., Galli S., Fabbiocchi F., Montorsi P., Veglia F., Bartorelli A. L., N-acetylcysteine and contrast-induced nephropathy in primary angioplasty New England Journal of Medicine 2006 354 26 2773 2782 (Pubitemid 43974195)
79. Kay J., Chow W. H., Chan T. M., Lo S. K., Kwok O. H., Yip A., Fan K., Lee C. H., Lam W. F., Acetylcysteine for prevention of acute deterioration of renal function following elective coronary angiography and intervention: a randomized controlled trial Journal of the American Medical Association 2003 289 5 553 558 (Pubitemid 37428626)
80. Webb J. G., Pate G. E., Humphries K. H., Buller C. E., Shalansky S., Al Shamari A., Sutander A., Williams T., Fox R. S., Levin A., A randomized controlled trial of intravenous N-acetylcysteine for the prevention of contrast-induced nephropathy after cardiac catheterization: lack of effect American Heart Journal 2004 148 3 422 429 (Pubitemid 39265114)
81. Boccalandro F., Amhad M., Smalling R. W., Sdringola S., Oral acetylcysteine does not protect renal function from moderate to high doses of intravenous radiographic contrast Catheterization and Cardiovascular Interventions 2003 58 3 336 341 (Pubitemid 36259222)
82. Briguori C., Manganelli F., Scarpato P., Elia P. P., Golia B., Riviezzo G., Lepore S., Librera M., Villari B., Colombo A., Ricciardelli B., Acetylcysteine and contrast agent-associated nephrotoxicity Journal of the American College of Cardiology 2002 40 2 298 303 (Pubitemid 34756291)
83. Briguori C., Colombo A., Violante A., Balestrieri P., Manganelli F., Elia P. P., Golia B., Lepore S., Riviezzo G., Scarpato P., Focaccio A., Librera M., Bonizzoni E., Ricciardelli B., Standard vs double dose of N-acetylcysteine to prevent contrast agent associated nephrotoxicity European Heart Journal 2004 25 3 206 211 (Pubitemid 38235156)
84. Baker C. S. R., Wragg A., Kumar S., De Palma R., Baker L. R. I., Knight C. J., A rapid protocol for the prevention of contrast-induced renal dysfunction: the RAPPID study Journal of the American College of Cardiology 2003 41 12 2114 2118 (Pubitemid 36724254)
85. Nallamothu B. K., Shojania K. G., Saint S., Hofer T. P., Humes H. D., Moscucci M., Bates E. R., Is acetylcysteine effective in preventing contrast-related nephropathy? A meta-analysis American Journal of Medicine 2004 117 12 938 947 (Pubitemid 40075562)
86. Bagshaw S. M., Ghali W. A., Acetylcysteine for prevention of contrast-induced nephropathy after intravascular angiography: a systematic reveiw and meta-analysis BMC Medicine 2004 2, article no. 38
87. Maioli M., Toso A., Leoncini M., Gallopin M., Tedeschi D., Micheletti C., Bellandi F., Sodium bicarbonate versus saline for the prevention of contrast-induced nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention Journal of the American College of Cardiology 2008 52 8 599 604
88. Patti G., Nusca A., Chello M., Pasceri V., D'Ambrosio A., Vetrovec G. W., Di Sciascio G., Usefulness of statin pretreatment to prevent contrast-induced nephropathy and to improve long-term outcome in patients undergoing percutaneous coronary intervention American Journal of Cardiology 2008 101 3 279 285 (Pubitemid 351162953)
89. Attallah N., Yassine L., Musial J., Yee J., Fisher K., The potential role of statins in contrast nephropathy Clinical Nephrology 2004 62 4 273 278 (Pubitemid 39386803)
90. Khanal S., Attallah N., Smith D. E., Kline-Rogers E., Share D., O'Donnell M. J., Moscucci M., Statin therapy reduces contrast-induced nephropathy: an analysis of contemporary percutaneous interventions American Journal of Medicine 2005 118 8 843 849 (Pubitemid 41097461)
91. Toso A., Maioli M., Leoncini M., Usefulness of atorvastatin (80 mg) in prevention of contrast-induced nephropathy in patients with chronic renal disease American Journal of Cardiology 2010 105 3 288 292
92. Xinwei J., Xianghua F., Jing Z., Xinshun G., Ling X., Weize F., Guozhen H., Yunfa J., Weili W., Shiqiang L., Comparison of usefulness of simvastatin 20 mg versus 80 mg in preventing contrast-induced nephropathy in patients with acute coronary syndrome undergoing percutaneous coronary intervention American Journal of Cardiology 2009 104 4 519 524
93. Kapoor A., Sinha N., Sharma R. K., Shrivastava S., Radhakrishnan S., Goel P. K., Bajaj R., Use of dopamine in prevention of contrast induced acute renal failurea randomised study International Journal of Cardiology 1996 53 3 233 236 (Pubitemid 26178156)
94. Gare M., Haviv Y. S., Ben-Yehuda A., Rubinger D., Bdolah-Abram T., Fuchs S., Gat O., Popovtzer M. M., Gotsman M. S., Mosseri M., The renal effect of low-dose dopamine in high-risk patients undergoing coronary angiography Journal of the American College of Cardiology 1999 34 6 1682 1688
95. Abizaid A. S., Clark C. E., Mintz G. S., Dosa S., Popma J. J., Pichard A. D., Satler L. F., Harvey M., Kent K. M., Leon M. B., Effects of dopamine and aminophylline on contrast-induced acute renal failure after coronary angioplasty in patients with preexisting renal insufficiency American Journal of Cardiology 1999 83 2 260 263 (Pubitemid 29047309)
96. Tumlin J. A., Wang A., Murray P. T., Mathur V. S., Fenoldopam mesylate blocks reductions in renal plasma flow after radiocontrast dye infusion: a pilot trial in the prevention of contrast nephropathy American Heart Journal 2002 143 5 894 903 (Pubitemid 34595351)
97. Stone G. W., McCullough P. A., Tumlin J. A., Lepor N. E., Madyoon H., Murray P., Wang A., Alan Chu A., Schaer G. L., Stevens M., Wilensky R. L., O'Neill W. W., Fenoldopam mesylate for the prevention of contrast-induced nephropathy: a randomized controlled trial Journal of the American Medical Association 2003 290 17 2284 2291 (Pubitemid 37430561)
98. Teirstein P. S., Price M. J., Mathur V. S., Differential effects between intravenous and targeted renal delivery of fenoldopam on renal function and blood pressure in patients undergoing cardiac catheterization American Journal of Cardiology 2006 97 7 1076 1081
99. Huber W., Ilgmann K., Page M., Hennig M., Schweigart U., Jeschke B., Lutilsky L., Weiss W., Salmhofer H., Classen M., Effect of theophylline on contrast material-induced nephropathy in patients with chronic renal insufficiency: controlled, randomized, double-blinded study Radiology 2002 223 3 772 779 (Pubitemid 34547597)
100. Kapoor A., Kumar S., Gulati S., Gambhir S., Sethi R. S., Sinha N., The role of theophylline in contrast-induced nephropathy: a case-control study Nephrology Dialysis Transplantation 2002 17 11 1936 1941 (Pubitemid 35277091)
101. Erley C. M., Duda S. H., Rehfuss D., Scholtes B., Bock J., Mller C., Osswald H., Risler T., Prevention of radiocontrast-media-induced nephropathy in patients with pre-existing renal insufficiency by hydration in combination with the adenosine antagonist theophylline Nephrology Dialysis Transplantation 1999 14 5 1146 1149 (Pubitemid 29209299)
102. Neumayer H.-H., Junge W., Kufner A., Wenning A., Prevention of radiocontrast-media-induced nephrotoxicity by the calcium channel blocker nitrendipine: a prospective randomised clinical trial Nephrology Dialysis Transplantation 1989 4 12 1030 1036 (Pubitemid 20135461)
103. Carraro M., Mancini W., Artero M., Stacul F., Grotto M., Cova M., Faccini L., Dose effect of nitrendipine on urinary enzymes and microproteins following non-ionic radiocontrast administration Nephrology Dialysis Transplantation 1996 11 3 444 448 (Pubitemid 26092782)
104. Khoury Z., Schlicht J. R., Como J., Karschner J. K., Shapiro A. P., Mook W. J., Weber R. J., The effect of prophylactic nifedipine on renal function in patients administered contrast media Pharmacotherapy 1995 15 1 I 59 65
105. Sketch M. H. Jr., Whelton A., Schollmayer E., Prevention of contrast media-induced renal dysfunction with prostaglandin E1: a randomized, double-blind, placebo-controlled study American Journal of Therapeutics 2001 8 3 155 162 (Pubitemid 33753112)
106. Spargias K., Alexopoulos E., Kyrzopoulos S., Iacovis P., Greenwood D. C., Manginas A., Voudris V., Pavlides G., Buller C. E., Kremastinos D., Cokkinos D. V., Ascorbic acid prevents contrast-mediated nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention Circulation 2004 110 18 2837 2842 (Pubitemid 39473606)
107. Kurnik B. R. C., Allgren R. L., Center F. C., Solomon R. J., Bates E. R., Weisberg L. S., Prospective study of atrial natriuretic peptide for the prevention of radiocontrast-induced nephropathy American Journal of Kidney Diseases 1998 31 4 674 680 (Pubitemid 28158009)
108. Vogt B., Ferrari P., Schnholzer C., Marti H.-P., Mohaupt M., Wiederkehr M., Cereghetti C., Serra A., Huynh-Do U., Uehlinger D., Frey F. J., Prophylactic hemodialysis after radiocontrast media in patients with renal insufficiency is potentially harmful American Journal of Medicine 2001 111 9 692 698 (Pubitemid 34017520)
109. Lehnert T., Keller E., Gondolf K., Effect of haemodialysis after contrast medium administration in patients with renal insufficiency Nephrology Dialysis Transplantation 1998 13 1 358 362 (Pubitemid 28062196)
110. Marenzi G., Lauri G., Campodonico J., Marana I., Assanelli E., De Metrio M., Grazi M., Veglia F., Fabbiocchi F., Montorsi P., Bartorelli A. L., Comparison of two hemofiltration protocols for prevention of contrast-induced nephropathy in high-risk patients American Journal of Medicine 2006 119 2 155 162 (Pubitemid 43151482)
111. Marenzi G., Marana I., Lauri G., Assanelli E., Grazi M., Campodonico J., Trabattoni D., Fabbiocchi F., Montorsi P., Bartorelli A. L., The prevention of radiocontrast-agent-induced nephropathy by hemofiltration New England Journal of Medicine 2003 349 14 1333 1340 (Pubitemid 37186211)
112. Spinosa D. J., Angle J. F., Hagspiel K. D., Kern J. A., Hartwell G. D., Matsumoto A. H., Lower extremity arteriography with use of iodinated contrast material or gadodiamide to supplement CO2 angiography in patients with renal insufficiency Journal of Vascular and Interventional Radiology 2000 11 1 35 43 (Pubitemid 30067206)
113. Erley C. M., Bader B. D., Berger E. D., Tuncel N., Winkler S., Tepe G., Risler T., Duda S., Gadolinium-based contrast media compared with iodinated media for digital subtraction angiography in azotaemic patients Nephrology Dialysis Transplantation 2004 19 10 2526 2531 (Pubitemid 39360099)
114. Briguori C., Colombo A., Airoldi F., Melzi G., Michev I., Carlino M., Montorfano M., Chieffo A., Bellanca R., Ricciardelli B., Gadolinium-based contrast agents and nephrotoxicity in patients undergoing coronary artery procedures Catheterization and Cardiovascular Interventions 2006 67 2 175 180 (Pubitemid 43235147)
115. Reed P. S., Dixon S. R., Boura J. A., O'Neill W. W., Kahn J. K., Comparison of the usefulness of gadodiamide and iodine mixture versus iodinated contrast alone for prevention of contrast-induced nephropathy in patients with chronic kidney disease undergoing coronary angiography American Journal of Cardiology 2007 100 7 1090 1093 (Pubitemid 47404463)
116. Boyden T. F., Gurm H. S., Does gadolinium-based angiography protect against contrast-induced nephropathy? A systematic review of the literature Catheterization and Cardiovascular Interventions 2008 71 5 687 693 (Pubitemid 351550413)
117. Gauden A. J., Phal P. M., Drummond K. J., MRI safety; nephrogenic systemic fibrosis and other risks Journal of Clinical Neuroscience 2010 17 9 1097 1104
118. Prince M. R., Zhang H. L., Roditi G. H., Risk factors for NSF: a literature review Journal of Magnetic Resonance Imaging 2009 30 6 1298 1308